187 related articles for article (PubMed ID: 38238398)
21. Epigallocatechin-3-gallate counters cisplatin toxicity of rat testes.
Fouad AA; Qutub HO; Fouad AEA; Audeh AM; Al-Melhim WN
Pharm Biol; 2017 Dec; 55(1):1710-1714. PubMed ID: 28478745
[TBL] [Abstract][Full Text] [Related]
22. Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.
de Wit R; Stoter G; Sleijfer DT; Neijt JP; ten Bokkel Huinink WW; de Prijck L; Collette L; Sylvester R
Br J Cancer; 1998 Sep; 78(6):828-32. PubMed ID: 9743309
[TBL] [Abstract][Full Text] [Related]
23. Low dose bleomycin with etoposide and cisplatin for metastatic testicular teratoma.
Coleman RE; Whillis D; Howard GC; Taylor RE; Cornbleet MA
Br J Urol; 1991 Sep; 68(3):296-300. PubMed ID: 1717098
[TBL] [Abstract][Full Text] [Related]
24. Tert-butylhydroquinone preserve testicular steroidogenesis and spermatogenesis in cisplatin-intoxicated rats by targeting oxidative stress, inflammation and apoptosis.
Nna VU; Ujah GA; Suleiman JB; Mohamed M; Nwokocha C; Akpan TJ; Ekuma HC; Fubara VV; Kekung-Asu CB; Osim EE
Toxicology; 2020 Aug; 441():152528. PubMed ID: 32565124
[TBL] [Abstract][Full Text] [Related]
25. The Effects of Glutathione on Clinically Essential Fertility Parameters in a Bleomycin Etoposide Cisplatin Chemotherapy Model.
Bayram H; Donmez Cakil Y; Sitar ME; Demirel G; Selam B; Cincik M
Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983969
[TBL] [Abstract][Full Text] [Related]
26. Transcriptome modulation following administration of luteolin to bleomycin-etoposide-cisplatin chemotherapy on rat LC540 tumor Leydig cells.
Nguyen HT; Couture R; Touaibia M; Martin LJ
Andrologia; 2021 Mar; 53(2):e13960. PubMed ID: 33400304
[TBL] [Abstract][Full Text] [Related]
27. Paternal exposure to testis cancer chemotherapeutics alters sperm fertilizing capacity and affects gene expression in the eight-cell stage rat embryo.
Maselli J; Hales BF; Robaire B
Andrology; 2014 Mar; 2(2):259-66. PubMed ID: 24478030
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.
Cary C; Jacob JM; Albany C; Masterson TA; Hanna NH; Einhorn LH; Foster RS
Clin Genitourin Cancer; 2018 Apr; 16(2):e307-e313. PubMed ID: 29104087
[TBL] [Abstract][Full Text] [Related]
29. One cycle of bleomycin, etoposide and cisplatin plus two cycles of etopeside and cisplatin chemotherapy in selected patients with low-volume stage II nonseminomatous germ cell tumor of the testis.
Mezvrishvili Z; Managadze L
Urol Int; 2005; 75(4):304-8. PubMed ID: 16327295
[TBL] [Abstract][Full Text] [Related]
30. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility.
Bieber AM; Marcon L; Hales BF; Robaire B
J Androl; 2006; 27(2):189-200. PubMed ID: 16278370
[TBL] [Abstract][Full Text] [Related]
31. Exposure to bleomycin, etoposide, and cis-platinum alters rat sperm chromatin integrity and sperm head protein profile.
Maselli J; Hales BF; Chan P; Robaire B
Biol Reprod; 2012 May; 86(5):166, 1-10. PubMed ID: 22402960
[TBL] [Abstract][Full Text] [Related]
32. Effect of Zinc on Spermatogenesis and Sperm Chromatin Condensation in Bleomycin, Etoposide, Cisplatin Treated Rats.
Razavi S; Khadivi F; Hashemi F; Bakhtiari A
Cell J; 2019 Jan; 20(4):521-526. PubMed ID: 30123998
[TBL] [Abstract][Full Text] [Related]
33. The effects of chemotherapy with bleomycin, etoposide, and cis-platinum on telomeres in rat male germ cells.
Liu M; Maselli J; Hales BF; Robaire B
Andrology; 2015 Nov; 3(6):1104-12. PubMed ID: 26446377
[TBL] [Abstract][Full Text] [Related]
34. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin.
Lauritsen J; Kier MG; Bandak M; Mortensen MS; Thomsen FB; Mortensen J; Daugaard G
J Clin Oncol; 2016 May; 34(13):1492-9. PubMed ID: 26903578
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic alterations in sperm DNA associated with testicular cancer treatment.
Chan D; Delbès G; Landry M; Robaire B; Trasler JM
Toxicol Sci; 2012 Feb; 125(2):532-43. PubMed ID: 22076425
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604).
Cafferty FH; White JD; Shamash J; Hennig I; Stenning SP; Huddart RA;
Eur J Cancer; 2020 Mar; 127():139-149. PubMed ID: 32007714
[TBL] [Abstract][Full Text] [Related]
38. Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEP.
de Wit R; Louwerens M; de Mulder PH; Verweij J; Rodenhuis S; Schornagel J
Int J Cancer; 1999 Dec; 83(6):831-3. PubMed ID: 10597204
[TBL] [Abstract][Full Text] [Related]
39. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin induced testicular damage through mitochondria mediated apoptosis, inflammation and oxidative stress in rats: impact of resveratrol.
A A Aly H; G Eid B
Endocr J; 2020 Sep; 67(9):969-980. PubMed ID: 32507773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]